consultant anaesthetist

JOB DESCRIPTION
LOCUM
CONSULTANT
TRANSPLANTATION
IN
PAEDIATRIC
HAEMATOLOGY
AND
BONE
MARROW
This is a locum replacement 4th post in paediatric haematology to cover maternity leave and to work with
the existing three consultants in paediatric haematology and in particular share responsibility for clinical
paediatric bone marrow transplantation with Professor Robert Wynn and clinical paediatric malignant
haematology with Professor Robert Wynn and Dr John Grainger. For the suitable candidate there will be
the opportunity to share duties with these 2 consultants and Dr Andrew Will in laboratory haematology.
THE TRUST
Central Manchester University Hospitals NHS Foundation Trust (CMFT) was established on 1 st January
2009 after being authorised by Monitor. Up until then it was known as Central Manchester and
Manchester Children's University Hospitals Trust which was founded on 1st April 2001. It brought together
Central Manchester Healthcare NHS Trust and the Manchester Children’s Hospitals NHS Trust following a
period of public consultation and the final decision by the Secretary of State.
As the leading provider of tertiary and specialist healthcare services in Manchester we treat more than a
million patients every year. Our five specialist hospitals are home to hundreds of world class clinicians and
academic staff committed to finding our patients the best care and treatments. The Trust is nearing
completion a major re-building programme through one of the largest PFI initiatives in the NHS.
ROYAL MANCHESTER CHILDREN’S HOSPITAL
The new Royal Manchester Children’s Hospital, a state of the art facility, opened in June 2009 as part of a
£0.5 billion hospital development comprising new facilities for the Royal Eye Hospital, St Mary’s Hospital and
much of the medical division of the Manchester Royal Infirmary. The hospital provides children’s
emergency, secondary and regional tertiary services, having brought together the services which were
provided across the Children’s Hospitals (Royal Manchester Children’s Hospital, RMCH, and Booth Hall
Children’s Hospital, BHCH) and St Mary’s Hospital for Women and Children. The alignment of these
secondary and tertiary services provides an impressive facility for children and babies from North West
England and should lead to a golden era of child health care in the Region.
The Royal Manchester Children’s Hospital is one of the largest children’s hospitals in Europe, adjacent to
leading adult tertiary services and University of Manchester Medical School. Clearly this offers huge
potential for future career development for the successful candidate.
The hospital provides all of the following Specialist Children’s Services: Gastroenterology, Respiratory
Medicine, Rheumatology, Neurology, Nephrology, Cardiology, Clinical Genetics, Endocrinology, Metabolic
Medicine, Oncology, Haematology, BMT, Paediatric Intensive Care, Burns and Plastics, Orthopaedics and
Trauma, Paediatric and Neonatal Surgery, Urology, Spinal Surgery, Otolaryngology. There is a
comprehensive Children’s Emergency Department, housed within the new hospital and a Child and
Family Psychiatry Unit.
HAEMATOLOGY AND ONCOLOGY UNIT
Consultant Staff

Dr Bernadette Brennan: Consultant Paediatric Oncologist, Clinical Lead haematology and
Oncology, full time NHS consultant for the Central Manchester Foundation Trust.

Dr John Grainger: Consultant Paediatric Haematologist, full time NHS consultant for the Central
Manchester Foundation Trust

Dr Andrew Will: Consultant Paediatric Haematologist and Haemophilia Unit Director, full time
funded consultant for the Central Manchester Foundation Trust
1

Professor Robert Wynn: Consultant Paediatric Haematologist and BMT Director, full time NHS
consultant for the Central Manchester Foundation Trust. Honorary Clinical Professor of
Haematology and Cellular Therapy

Dr Denise Bonney: Consultant Paediatric Haematologist, full time NHS consultant for the Central
Manchester Foundation Trust

Professor Vaskar Saha:
Consultant).

Dr Guy Makin: Senior Lecturer Paediatric Oncology (Honorary Consultant).

Dr Stefan Meyer: Senior Lecturer Paediatric Oncology (Honorary Consultant).

Dr Anthony Penn, Consultant Paediatric Oncologist, full time NHS consultant for the Central
Manchester Foundation Trust

Dr JP Kilday, Consultant Paediatric Oncologist, full time NHS
Manchester Foundation Trust
Cancer Research UK, Professor of Paediatric Oncology (Honorary
consultant for the Central
Junior Medical Staff
All junior staff are based solely in the Haematology and Oncology unit, area rather than consultant based.
ST3
ST4 +
ST4 +
Paediatrics (4) – 3 based on ward 84 and for patients outlying on other wards, 1 based on
BMT – 4-6 month slots
Paediatrics (3)– 1 each based on ward, outpatients and on outlying wards – currently one
higher specialist trainee in paediatric oncology (national grid trainee) out of service for
research– 6 month slots
Adult Haematology (1-2) – 1 based BMT/leukaemia, 1 based haemoglobolopathies/
haemophilia unit – 6 month slots. There is at any one time a Paediatric Haematology SPR
in the region but at any one time they may be away from the paediatric haematology
service for example whilst carrying out core training in adult haematology.
The middle grade paediatric staff are part of an on call shift system which up to 9 pm provide cover for the
Haematology and Oncology patients only. At night they also cover other areas in a total of a 11 doctor
cell. The haematology SPRs provide on call for Paediatric haematology only on an incomplete 1 in 5 rota.
Unit Facilities
There is high quality nursing support both on the ward and in a dedicated haematology and oncology
outpatients lead by a Modern Matron and a lead nurse for Haematology and Oncology, Sue Crook. The
nursing service includes a separate haemophilia treatment centre and haematology specialist nurses,
specialist nurses in BMT, outreach nurses for paediatric oncology and research nurses in oncology and
non malignant haematology.
Ward 84 (haematology and oncology inpatients – 12-20 beds)
The ward is dedicated to haematology and oncology open to 20 beds Monday to Friday to allow for
planned overnight admissions. Other wards in the children’s division are used for outliers.
Bone Marrow Transplant Unit (7 beds)
The 7 bedded unit is used solely for transplantation admissions and patients with transplant related
morbidity. It is geographically located next to ward 84 and the haematology and oncology OPD. Each
cubicle has en-suite facilities and each has laminar air flow.
Day Case/Outpatient Unit
18 bedded day case Unit - Planned chemotherapy, blood product and immunoglobulin infusions – and a
separate theatre and recovery area for procedures e.g. bone marrows etc. Separate unit for haemophilia
treatment and nurse led services for home treatment teaching.
Outpatients – dedicated unit OPD for oncology, haematology, BMT and leukaemia clinics in total 14 per
week. All clinics supported by either OPD nurses or dedicated clinical nurse specialists.
The whole department is supported by 2 whole time equivalent oncology/haematology pharmacists,
paediatric dietician, paediatric physiotherapist and half time clinical psychologist.
The Pathology Department
The 4 consultant paediatric haematologists all have laboratory responsibility including sharng on call for
laoratory paediatric haematology. This might not be an essential part of this temporary replcaement
poisition. The Department of Pathology is part of Clinical Support Services Directorate of the Central
Manchester University Hospitals NHS Foundation Trust (CMFT). The Haematology laboratory is a shared
facility with adult services and is based in the Manchester Royal Infirmary Hospital but includes separate
paediatric haematology, transfusion and coagulation areas with dedicated paediatric staff and a separate
on call rota for biomedical staff. There is a harmonised pathology service providing biochemistry,
microbiology, virology and histopathology.
There is a dedicated therapeutic stem cell laboratory and Professor Wynn is the medical director. This
facility is both JACIE and HTA accredited and provides stem cell facilities to both adult and paediatric
BMT Programmes in CMFT
Laboratory Staff (Haematology)
BMS 4, Roy Kettle
BMS3 in Transfusion/Stem cell
BMS2 Transfusion
BMS3 in Haematology
BMS 2 in Haematology
BMS 1 staff 8.5 wte
MLA staff 1 works in all areas plus phlebotomy
Reception
1 MTO reception manager
MLA 3 wte (reception and phlebotomy)
There is recognition by the CPSM for training
Tertiary Paediatric Haematology Services
This unit is the tertiary paediatric oncology centre and Haemophilia Centre for the North West Region
receiving referrals from Barrow in Furness to Crewe.
The haematology department is one of the busiest clinical departments in the medical directorate with
large numbers of inpatients, day cases and outpatients. A large proportion of the patients have potentially
life threatening diseases and malignancies. Manchester is the third largest oncology centre in the UK with
one of the larger Paediatric BMT units.
3
Services provided include full laboratory service, leukaemia diagnosis and management, general
haematology, haemophilia and other coagulopathies, bone marrow transplantation and an advice service
to district general paediatricians in the region for general paediatric haematology, anticoagulation and the
management of thrombosis.
Departmental Workload

Clinical
The clinical service is a tertiary service for the North West Region with a small proportion of the general
haematology as a secondary service for Central Manchester and other specialities.
Bone marrow transplantation: 35 allogeneic transplants per year - most of which unrelated donor and
there is a significant use of unrelatated cord blood. There is a small number of autlogous transplant too.
The unit has particular expertise in metabolic disease transplant and had performed more transplants for
such indications than any other centre in Europe including about 50 children with MPSIH in the last 10
years. The Unit is part of the BSBMT and its paediatric group. It follows national indications, protocols etc
and participates in national audit. The Unit has been JACIE accredited since 2007. The Unit has close
links with the University and there are many publications from this relationship particulalry in metabolic
disease SCT and pre-clinical gene therapy and has performed several “first in man” transplants.
Leukaemia: 30-40 new/relapsed leukaemic patients per year.
General Haematology: Inherited and acquired blood disorders including haemoglobinopathies (50
Thalasaemics, 120 Sickle cell disease), inherited cytopenias, acquired cytopathies and haemolytic
anaemias.
Haemophilia: 250 patients registered with serious coagulation problems.
(Non –haematological malignancies – 80 per year)
Laboratory haematology and blood transfusion
Haematology provides routine and emergency investigations. as well as more specialist testing such as
factor assays and platelet function studies. The throughput is approximately 150 FBCs per day, 50
coagulation tests and 50 cross matches per week. 25 bone marrow smears/C.S.F. cytology/bone marrow
trephines and 100 blood films per week . The laboratory is CPA accredited.
The laboratory also offers a number of diagnostic services based on Flow Cytometry. Transfusion
provides a grouping, screening and cross-matching service. Blood products are supplied to support the
clinical work of all departments at The RMCH and Booth Hall Sites. The laboratory offers an autologous
blood transfusion service. Equipment includes Sysmex XE2100 FBC analyser, two KX21 analyser,
Biomerieux MDA coagulation analyser, PFA100, PAP4 platelet aggregation,
DUTIES AND EXPERIENCE REQUIRED
The locum consultant will be responsible for in- and out-patient bone marrow transplant patients in an
attending system, alternating with Prof R F Wynn who is the BMT program director. The post holder will
be expected to attend for 6 months per year. Approximately 35 bone marrow transplants are performed
annually, and the majority are unrelated allografts. The unit has particular expertise in the transplantation
of children with MPS and other inborn errors of metabolism. The majority of transplant in the Unit are for
non malignant diseases. The Unit has JACIE accreditation after inspection in 2007. The number of Units
performing transplants in the North West of England is currently under review.
The BMT MDT includes Dr S Hughes, Consultant Paediatric Immunologist, Dr A Turner, Consultant
Clinical Virologist, the Therapeutic Stem Cell Laboratory as well as dedicated dietetic, nursing, social work
practioners.
The Unit has a research programme including a preclinical research programme, that is mainly focussed
on BMT in non malignant disease. There are active clinical and research collaborative links. The Unit is an
active member of the EBMT, including the Inborn Error Working Party and Paediatric diseases Working
Party. The appointee would be encouraged to engage in clinical research, or collaborative preclinical
research.
The locum consultant will also be expected to take responsibility for the diagnosis and management of
patients with leukaemia along side Professor R Wynn and Dr J Grainger one week in three. There are
some 30 new acute leukaemia cases per year.
The locum consultant will take on the diagnosis and care of patients with general haematological
conditions during that “take” week or referred from general paediatricians. Patients with inherited bleeding
disorders are referred to the Haemophilia Reference Centre, directed by Dr A M Will and shared with Dr
John Grainger.
For those with appropriate training and interest laboratory duties will be shared equally with the existing
haematology consultants. All tertiary paediatric specialities are represented in the children’s division
which include a paediatric intensive care unit. The consultant paediatric haematologists are also
expected to give advice and review results and blood films across the entire CMFT and from all hospitals
within our large catchment area, approximately 12% of the UK population. Lead managerial consultant
haematologist duties for the laboratories are shared equally on a three yearly rotational basis.
The post holder will have the MRCP or MRCPH. A CCST in Haematology must have been awarded or be
able to apply for such within 6 months. Evidence of particular training in Paediatric Haematology and BMT
will be required. For those that possess also the FRCPath or equivalent then there will be the opportunity
to partcipate in laboratory duties.
The timetable for the new consultant varies on whether attending BMTU or not – see subsequent job plan.
The attending rotation is currently monthly. Core fixed commitments to BMTU remains such as MDT ward
rounds, BMT planning and quality meetings. There is a fixed malignant haematology clinic included.
The on-call commitment is currently one night a week, Monday to Thursday and every fourth weekend
(Friday to Sunday), all with prospective cover. The weekends on-call are of two types; first on call and
second on call. First on call weekends involve taking primary responsibility for the care of all the unit’s
inpatients including patients with solid tumours, with a second on call oncology consultant available to
give advice on difficult clinical problems involving solid tumour patients. In second on call weekends, the
haematology consultant needs to be able to give similar clinical advice to the first on call oncology
consultant concerning any difficult clinical problems with haematology inpatients. During all on call
weekends, the haematologist is responsible for dealing with any laboratory-based haematology problems
and giving advice on haematological problems to clinicians on other units or from other hospitals. There is
always junior doctor cover with a SpR and SHO on call specifically for clinical haematology and oncology.
On about every third week night and third weekend on call there is also a first on call haematology SpR to
help the haematology consultant. The exact on call commitments will be negotiated according to the
training of the candidate and specifically the abiity and qualificiations to participte in laboratory
haematology
The appointee will be contracted for 10 programmed activities per week; approximately 8.5 PAs for direct
clinical care, the remainder will cover supporting professional activities.
The appointee would be expected to cover for colleagues on annual, study and short term sick leave. The
consultant will provide continuing responsibility for patients in their charge and in partnership with
colleagues working for the proper function of the department. The post holder may be required to
undertake other duties appropriate for a consultant paediatric haematologist not otherwise specified.
For an appointee in their first Consultant post, one of the rostered sessions will be a mentored one to
facilitate acclimatisation to the role and the organisation. In these circumstances, that session will be
considered as a developmental component and badged as SPA time
5
A suggested work plan is attached.
RESEARCH
All patients, where appropriate, are enrolled on MRC and CCLG trials. All BMT patients are registered
and followed by the CCLG and EBMT registries. Data managers provide support for this research. Trials
are ongoing in non malignant haematology and BMT supportive care. Consultants are encouraged to take
on other personal research.
The BMTU has an excellent publication record and contributes to international collaborative research
particularly in metabolic research.
Research and Innovation.
The vision of CMFT is to become the leading integrated health, teaching, research and innovation campus
in the NHS. Within this context our aim over the next 5 years is to ensure that CMFT is one of the top 5
NHS Trusts for research and innovation in the U.K. Our capacity for translation of research and
innovation into improved patient care will be internationally recognised, both in its own right and in
partnership with Manchester Academic Health Science Centre (http://www.mahsc.ac.uk/). We have a
number of important assets to help us achieve this ambitious goal:







We have just completed a new hospital development, co-located with the University of
Manchester to create the largest biomedical research campus in Europe
The Manchester NIHR Biomedical Research Centre (http://www.cmft.nhs.uk/brc/biomedicalresearch-centre.aspx), a partnership with the University of Manchester, is one of 12 such elite
centres in the UK.
The Wellcome Trust Clinical Research Facility (WTCRF), purpose built for experimental medicine
research and incorporating an MRI research scanner suite, is one of only 4 in the UK with both
adult and paediatric facilities.
The Centre for Applied Diagnostics and Experimental Therapeutics, a multimillion pound new
development uniquely designed and built within the hospital to enable application of proteomics,
metabolomics and genomics to experimental medicine.
A recently opened and staffed Biobanking facility, now collecting a range of well phenotyped
human tissues for research within CMFT and across MAHSC.
The largest single site clinical sciences centre in the UK.
Our clinical research and innovation benefits from established partnerships with:
o TrusTECH, the NHS Innovation Hub in the Northwest
o MIMIT (Manchester Integrating Medicine and Innovative Technology), providing solutions
to unmet clinical need.
o Manchester Medical Technologies Development Centre, designed to accelerate the
development of new devices and diagnostics
o Greater Manchester Comprehensive Local Research Network
o Medicines for Children Research Network
o ICON Development Solutions
o Wyeth Pharmaceuticals
o Science & Technology Facilities Council at Daresbury
These assets, coupled with a network of Clinical Division Research Leads and Research Managers
enabling research throughout the organisation, and a system of internal pump priming grants, provide a
first class environment for translational research in a hospital setting.
TEACHING
The locum consultant will be expected to participate in the teaching activities of the paediatric
haematology and oncology unit. These include a weekly haematocytopathology meeting on Wednesday
am, a histopathology meeting on Thursday am and unit teaching on Tuesday afternoon.
The post holder will also be expected to teach medical students and junior doctors attached to the unit
and be prepared to have postgraduate and undergraduates attend their outpatient clinics. Our unit’s
consultants are actively encouraged to become involved in the teaching of nurses and other professions
involved in the multidisciplinary care of our patients.
The unit is accredited by the SAC and Royal College of Physicians for the training of specialist registrars
in adult and paediatric haematology. All the North West regional Haematology SPRs spend 6 months in
the unit, two at any one time from a pool of 18. The training is extended to two years for trainees in
paediatric haematology.
The unit is also accredited by the Royal College of Paediatrics and Child Health for higher specialist
training in Paediatric Oncology
The consultants also contribute to the provision of education to nursing staff and occasionally to other
units in the trusts. There is a weekly Grand Round within the Children’s Hospital and the Trust has a large
dedicated Postgraduate Centre where there are weekly Grand Rounds for the Trust as a whole. In
addition, there are twice weekly educational meetings for doctors within the department and regional
courses for postgraduate teaching.
MANAGEMENT
The Clinical Head of Division of Children’s Services is Mr James Bruce, Consultant Surgeon. The
Associate Head of Division is Miss Naomi davis. The Director of Children’s Services is Mr Alwyn Hughes.
With the advent of clinical governance, it is expected that all consultants will work together with senior
nursing staff on different aspects of the trust governance framework to ensure that the paediatric
department runs a high quality, low risk service which includes good education for staff and an established
system of ongoing audit. Past experience of audit and a commitment to undertaking quality audits in post
is essential as is some previous managerial experience.
The new consultants will be expected to share with the existing consultants in mentoring and supervising
junior medical staff in the hospital and to contribute to managerial duties within the department.
The post holders will be expected to participate in the clinical governance arrangements for hospital
services. The post holders are accountable to the clinical directors, and responsible to the Chief
Executive.
CPD
All consultants currently in post easily achieve more than the minimum internal and external CPD targets.
Study leave and professional leave are granted by the trust to support appropriate educational activities
according to royal college guidelines.
Mentoring will be offered to the successful applicants as well as annual appraisal and job plan review.
CLINICAL AUDIT
The appointee will be expected to participate in Medical Audit. Audit facilitators are based on site.
APPRAISAL AND JOB PLAN REVIEW
Annual Appraisal is now obligatory for all consultants and will include an annual Job Plan review.
JOB SHARE/PART TIME
Any consultant who is unable for personal reasons to work full time will be eligible to be considered for the
post. We are willing to modify the job content to suit the individual but within the limits of Trust policies and
the needs of the department. This we would be happy to discuss on an individual basis with applicants.
CONTINUING MEDICAL EDUCATION
The Trust is committed to supporting CME for all specialists with both time and financial support.
7
INFORMATION TECHNOLOGY
You are encouraged to pro-actively seek to work with the Trusts information technology resources, to
exploit the full benefits of information technology in delivering improved patient care.
MAINTAINING MEDICAL EXCELLENCE
The Trust is committed to providing safe and effective care for patients. To ensure this there is an agreed
procedure for medical staff that enables them to report quickly and confidentially, concerns about the
conduct, performance or health of medical colleagues (Chief Medical Officer, December 1996). All
medical staff practising in the Trust should ensure that they are familiar with the procedure and apply it.
RISK MANAGEMENT
The Trust has a Risk Management Strategy. All Consultant Medical Staff are required to adhere to the
principles and practices contained therein.
OFFICE AND SECRETARIAL SUPPORT
The post holder will be provided with an office/op room and designated secretarial support along with
access to appropriate IT facilities.
VISITS
Prospective candidates may contact Dr Bernadette Brennan, Clinical Lead on 0161 701 8419
Email: [email protected] or
Professor Robert Wynn – Consultant in Paediatric Haematology and BMT on 0161 701 8454
Email: [email protected] .
JOB PLAN
Day
Monday
Tuesday
Wednesday
Thursday
Friday
Saturday/
Sunday
Time
Location
0900-1100 RMCH
1100-1300 RMCH
1300-1400 RMCH
1400-1700 RMCH
1300-1700 RMCH
0900-1300 RMCH
1300-1400 RMCH
1400-1500 RMCH
1500-1700 RMCH
0830-0900 RMCH
0900RMCH
12.30
1230-1330 RMCH
1330-1630 RMCH
0900-1300 RMCH
1300-1400 RMCH
1400-1600 RMCH
0900-1300 RMCH
Work
Joint consultant BMT round (Both parts of job)
BMT MDT meeting (both parts of job)
Patient administration BMT service) *alternate weeks
BMT OPD (BMT Service) *alternate weeks
½ day not in BMT service*alternate weeks
Ward rounds/Lab
CPD
Multidisciplinary Meeting
Teaching/ Clinical management
Morphology meeting/Leukaemia MDT
Ward Rounds and patient admin, seeing new BMT
patients (when BMT service)
X-ray meeting
Operating /pre op clinic
Leukaemia Clinic
BMT or ward Leukaemia rounds/Lab
research
BMT OPD 1/2 or BMT Rounds/lab ½
Code
C4
C7
C11
C2
PAs
0.5
0.5
0.25
0.375
1300-1400
Audit
S4
1400-1700 RMCH
Handover Round /theatre/1/2 day when BMT
service
C4/C3 0.375
C2/C13 1
S2
0.25
C7
0.25
S3/S7 0.5
C4/C8 0.125
C4,C2, 0.875
C11
C7
0.25
C2/C3 0.75
C2
1.0
C2/C13 0.25
S6
0.5
C3/C4 1.0
0.25
Additional
agreed activity
to be worked
flexibly
Travel
Predictable
0800-0830
RMCHemergency on- 0830-1430
WR
call work
1430-1500
Travel
Unpredictable
emergency oncall work
TOTAL PA’s
1 hr/w’kend
12hrs/w’kend
1 hr/w’kend
0.8
2nd. On weekend (4hrs in) .
Week nights 4 hrs
0.2
10.00
1:4
A
8%
Programmed Activity
Number
Direct clinical care (including unpredictable on-call)
8.5
Supporting professional activities
1.5
Other NHS responsibilities
External Duties
TOTAL PROGRAMMED ACTIVITIES
10.00
2. On-call Rota Details
Please complete either section A or section B depending on the nature of your on-call.
Do you participate in an on-call rota?
YES
What is the frequency of your on-call? (i.e. 1:3/1:4)
(delete as appropriate)
1:4 ...............................................................
How often are you called in, and what is the average time spent in the hospital? .........................
On-call availability supplement
Agreed on-call rota e.g. 1 in 5:
Agreed category (delete):
On-call supplement e.g. 5%:
9
3. Objectives
Objectives and how they will be met
Divisional objectives will include assistance to meet waiting time targets and achieve financial control.
Personal objectives will be agreed with the successful applicant as part of the appraisal process.
4. Support identified in order to deliver commitments e.g. facilities, training and development
The appointee will be supported by a medical secretary, junior medical staff and Nurse Specialists.
Support will also be available from the Internal Training and Development/Audit department.
5. Additional NHS responsibilities and/or external duties
Specify how any responsibilities or duties not scheduled within the normal timetable will be dealt with
A request for these needs to be submitted to the Clinical Head of Division and the Divisional Director.
Whilst the Trust acknowledges the possible benefits for both the individual and the Trust, commitments
to the NHS must be the priority.
Note: In addition to regular duties and commitments, the consultant might have certain ad-hoc
responsibilities. These would normally but not exclusively fall into the “additional NHS responsibilities” or
“external duties” categories of work, for example member of an Advisory Appointments Committee or work
for a Royal College. Such duties could be scheduled or agreement could be reached to deal with such
work flexibly. The method of dealing with such commitments should be set out in the box above.
6. Other comments or agreements
Detail any other specific agreements reached about how the job plan will operate. For example, with
regard to category 2 fees, domiciliary consultations and location flexibility.
No additional NHS responsibilities have been identified.
0
PERSON SPECIFICATION
Requirements
Essential / Desirable Method of Assessment
Qualifications and Training
MBChB or equivalent
Essential
Postgraduate qualification or equivalent MRCP or
Essential
MRCPCH and MRCPath
Completion of general professional training
Essential
(paediatrics and/or general medicine).
Completion of higher training (CCST Haematology)
This should include 2 years of paediatric haematology
with an absolute minimum of 12 months paediatric
Essential
haematology in a paediatric haematology centre and at
least one year in Paediatric BMTU.
MD, PhD or other higher degree
CV
CV
CV
CV
Desirable
CV
Essential
CV and Interview
Essential
CV and Interview
Desirable
CV and Interview
Teaching and Audit
Teaching medical students
Teaching junior medical staff
Experience of Audit
Academic Achievements and Research
1
1
Publications in peer reviewed journals or
demonstrable commitment to developing research in Essential
the Trust (haematology and BMT)
CV and interview
A specialist interest in BMT
Essential
CV and Interview
Research Projects relating to BMT
Desirable
CV and Interview
Interpersonal Skills
Interview, References and
Presentation
Interview, References and
Presentation
Organisation skills
Essential
Communication skills
Essential
Leadership skills
Essential
Interview and References
Ability to work harmoniously in multidisciplinary team Essential
Interview, References and
Presentation
Other Requirements
Full registration with the GMC
Essential
CV and Certificates
Registered on the GMC Specialist Register (or be
within 6 months of CCT date from the date of
interview)
Essential
CV and Certificates
Candidates Name:
Candidates Signature:
Date:
2